A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

Abroad (travel likely)RecruitingPHASE3

Conditions

IgA Nephropathy (IgAN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Guangdong Provincial People's Hospital, Guangzhou, Yuexiu District, China
Contact: Study coordinator (Yu Xueqing, Prof) · yuxueqing@gdph.org.cn · 020-83827812

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

IgA Nephropathy (IgAN)

Abroad (travel likely)RecruitingPHASE3

Huangshan City, China · Wuhu, China

Study of Ravulizumab in Pediatric Participants With Primary IgAN

IgAN · IgAVN · Immunoglobulin A Nephropathy

Abroad (travel likely)RecruitingPHASE3

Palo Alto, United States · Aurora, United States

Atacicept in Multiple Glomerular Diseases

pMN · IgAN · Nephrotic Syndrome

Abroad (travel likely)RecruitingPHASE2

Brisbane, United States

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

IgA Nephropathy (IgAN)

Abroad (travel likely)Recruiting

Paris, France